Get started
Author

Yu‐Shan Wu

The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
2011 · Chung-Pu Wu, Chia-Hung Hsieh, et al. · Molecular Pharmaceutics · 241
Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system
2005 · Der-Ren Hwang, Yu-Shan Wu, et al. · Bioorganic & Medicinal Chemistry · 124
Portal Venous and Hepatic Arterial Coefficients Predict Post-Hepatectomy Overall and Recurrence-Free Survival in Patients with Hepatocellular Carcinoma: A Retrospective Study
2024 · Yu-Kai Li, Song Wu, et al. · Journal of Hepatocellular Carcinoma · 105
PDF
Scaffold-Hopping Strategy: Synthesis and Biological Evaluation of 5,6-Fused Bicyclic Heteroaromatics To Identify Orally Bioavailable Anticancer Agents
2011 · Yen-Shih Tung, Mohane Selvaraj Coumar, et al. · Journal of Medicinal Chemistry · 97
Synthesis and Evaluation of 3-Aroylindoles as Anticancer Agents: Metabolite Approach
2009 · Yu-Shan Wu, Mohane Selvaraj Coumar, et al. · Journal of Medicinal Chemistry · 92
Treatment of Spinocerebellar Ataxia with Mesenchymal Stem Cells: A Phase I/IIa Clinical Study
2017 · Yun-An Tsai, Ren-Shyan Liu, et al. · Cell Transplantation · 68
Generation of Ligand-Based Pharmacophore Model and Virtual Screening for Identification of Novel Tubulin Inhibitors with Potent Anticancer Activity
2009 · Yi-Kun Chiang, Ching-Chuan Kuo, et al. · Journal of Medicinal Chemistry · 64
Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2
2023 · Chung-Pu Wu, Sung-Han Hsiao, et al. · Drug Resistance Updates · 51
Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs
2020 · Chung-Pu Wu, Sung-Han Hsiao, et al. · Cancers · 51
PDF
Antiviral Drug Discovery Against SARS-CoV
2006 · Yu-Shan Wu, Wen-Hsing Lin, et al. · Current Medicinal Chemistry · 44
Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
2020 · Chung-Pu Wu, Tai-Ho Hung, et al. · Cancers · 43
PDF
Multidrug resistance: The clinical dilemma of refractory Helicobacter pylori infection
2021 · Chia-Jung Kuo, Cheng-Han Lee, et al. · Journal of Microbiology Immunology and Infection · 39
PDF
Alpha-Mangostin Reverses Multidrug Resistance by Attenuating the Function of the Multidrug Resistance-Linked ABCG2 Transporter
2017 · Chung-Pu Wu, Sung-Han Hsiao, et al. · Molecular Pharmaceutics · 38
Stable Cu+/Cu2+ species derived from in-situ growing Cu-S-V bonds in CuVxS electrocatalysts enables high efficiency CO2 electroreduction to methanol
2024 · Xuli Hu, Zhen Zhang, et al. · Applied Catalysis B: Environmental · 35
Human ATP-Binding Cassette Transporter ABCG2 Confers Resistance to CUDC-907, a Dual Inhibitor of Histone Deacetylase and Phosphatidylinositol 3-Kinase
2016 · Chung-Pu Wu, Ya-Ju Hsieh, et al. · Molecular Pharmaceutics · 34
Intercalation into the DNA double helix and in vivo biological activity of water-soluble planar [Pt(diimine)(N,N-dihydroxyethyl-N′-benzoylthioureato)]+Cl− complexes: A study of their thermal stability, their CD spectra and their gel mobility
2005 · Yu-Shan Wu, Klaus R. Koch, et al. · Archives of Biochemistry and Biophysics · 29
Antihelminthic niclosamide modulates dendritic cells activation and function
2014 · Chieh-Shan Wu, Yi-Rong Li, et al. · Cellular Immunology · 26
PDF
SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines
2018 · Chung-Pu Wu, Megumi Murakami, et al. · Cancer Letters · 24
PDF
Diagnosis of Pneumocystis pneumonia by real-time PCR in patients with various underlying diseases
2019 · Shu-Li Yang, Ying-Hao Wen, et al. · Journal of Microbiology Immunology and Infection · 23
PDF
Tyrphostin RG14620 selectively reverses ABCG2-mediated multidrug resistance in cancer cell lines
2017 · Chung-Pu Wu, Sung-Han Hsiao, et al. · Cancer Letters · 22
Human ATP-binding cassette transporters ABCB1 and ABCG2 confer resistance to histone deacetylase 6 inhibitor ricolinostat (ACY-1215) in cancer cell lines
2018 · Chung-Pu Wu, Ya-Ju Hsieh, et al. · Biochemical Pharmacology · 21
Facilitating Anti-Cancer Combinatorial Drug Discovery by Targeting Epistatic Disease Genes
2018 · Yuan Quan, Meng-Yuan Liu, et al. · Molecules · 21
PDF
Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells
2023 · Chung-Pu Wu, Yen-Ching Li, et al. · International Journal of Molecular Sciences · 19
PDF
AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways
2017 · Yi-Hua Lai, Sih-Yin Lin, et al. · Journal of Hematology & Oncology · 19
PDF
Synergistic Activity of an Antimetabolite Drug and Tyrosine Kinase Inhibitors against Breast Cancer Cells
2017 · Yushan Wu, Dongxing Zhang, et al. · Chemical and Pharmaceutical Bulletin · 18
PDF
Works count: 65
Citation count: 1,608
H-index: 21
I10-index: 37
Year
Topic
Type